Evidence map›Paper›PMID 40260919›Full record

ArticleJCI insight2025

Testosterone affects female CD4+ T cells in healthy individuals and autoimmune liver diseases.

Lara Henze, Nico Will, Dakyung Lee, Victor Haas, Christian Casar, Jasper Meyer, Stephanie Stein, Franziska Mangler, Silja Steinmann, Tobias Poch and 11 more

Abstract read
In one paragraph

Article in JCI insight, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Sex Hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Lara Henze1st Department of Medicine, and.
Nico Will1st Department of Medicine, and.
Dakyung Lee1st Department of Medicine, and.
Victor Haas1st Department of Medicine, and.
Christian Casar1st Department of Medicine, and.
Jasper Meyer1st Department of Medicine, and.
Stephanie Stein1st Department of Medicine, and.
Franziska Mangler1st Department of Medicine, and.
Silja Steinmann1st Department of Medicine, and.
Tobias Poch1st Department of Medicine, and.
Jenny Krause1st Department of Medicine, and.
Johannes FussInstitute of Forensic Psychiatry and Sex Research, Center for Translational Neuro and Behavioral Sciences, University of Duisburg-Essen, Essen, Germany.
Johanna SchröderInstitute for Clinical Psychology and Psychotherapy, Department for Psychology, Medical School Hamburg, Hamburg, Germany.
Alexandra E KulleDivision of Pediatric Endocrinology and Diabetes, Department of Children and Adolescent Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Paul-Martin HolterhusDivision of Pediatric Endocrinology and Diabetes, Department of Children and Adolescent Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Stefan BonnInstitute of Medical Systems Biology and.
Marcus AltfeldResearch Department Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.
Samuel Huber1st Department of Medicine, and.
Ansgar W Lohse1st Department of Medicine, and.
Dorothee Schwinge1st Department of Medicine, and.
Christoph Schramm1st Department of Medicine, and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) are autoimmune liver diseases with strong female predominance. They are caused by T cell-mediated injury of hepatic parenchymal cells, but the mechanisms underlying this sex bias are unknown. Here, we investigated whether testosterone contributes to T cell activation in women with PBC. Compared with sex- and age-matched healthy controls (n = 23), cisgender (cis) women with PBC (n = 24) demonstrated decreased testosterone serum levels and proinflammatory CD4+ T cell profile in peripheral blood. Testosterone suppressed the expression of TNF and IFN-γ by human CD4+ T cells in vitro. In trans men receiving gender-affirming hormone therapy (GAHT) (n = 25), testosterone affected CD4+ T cell function by inhibiting Th1 and Th17 differentiation and by supporting the differentiation into regulatory Treg. Mechanistically, we provide evidence for a direct effect of testosterone on T cells using mice with T cell-specific deletion of the cytosolic androgen receptor. Supporting a role for testosterone in autoimmune liver disease, we observed an improved disease course and profound changes in T cell states in a trans man with AIH/primary sclerosing cholangitis (PSC) variant syndrome receiving GAHT. We here report a direct effect of testosterone on CD4+ T cells that may contribute to future personalized treatment strategies.

Indexed as

CD4-Positive T-LymphocytesHepatitis, AutoimmuneLiver Cirrhosis, BiliaryTestosteroneAdultAnimalsCell DifferentiationFemaleHumansLymphocyte ActivationMaleMiceMiddle AgedReceptors, AndrogenTh17 CellsT-Lymphocytes, RegulatoryReceptors, AndrogenTestosteroneAutoimmune diseasesAutoimmunityHepatologyImmunologySex hormonesT cells

Identifiers

PMID40260919
PMCPMC12016935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.